InvestorInformation
Latest Annoucements
-
Schedule of Investors /Analysts’ call with Management on 09.02.2023 and Registration Log-in details for the same
01.02.2023 Read More -
Presentation at JP Morgan Healthcare Conference, SFO US
10.01.2023 Read More -
Disclosure of material event – Updates on acquisition
22.12.2022 Read More -
Disclosure of Material Event – Allotment of Equity Shares on exercise of Stock options pursuant to ESOP Scheme
21.12.2022 Read More -
Press Release in relation to acquisition of ‘Razel’ franchise from Glenmark Pharmaceuticals Limited
14.12.2022 Read More -
Disclosure of Material Event – Acquisition
14.12.2022 Read More
-
Disclosure of Material Event – Q2 FY 23 Earnings Call Transcript
18.11.2022 Read More -
Disclosure of Material Event – Allotment of Equity Shares on exercise of Stock options pursuant to ESOP Scheme
17.11.2022 Read More -
Audio recording of earnings conference call
15.11.2022 Read More -
Q2 FY23 Press Release / News
12.11.2022 Read More -
Q2 FY23 Investor Presentation
12.11.2022 Read More -
Q2 FY23 Results Sheet
12.11.2022 Read More
-
Schedule of Investors /Analysts’ call with Management on 14.11.2022 and Registration Log-in details for the same
07.11.2022 Read More -
Disclosure of Material Event – Allotment of Equity Shares on exercise of Stock options pursuant to ESOP Scheme
13.09.2022 Read More -
Disclosure of Material Event – Proceedings of AGM
25.08.2022 Read More -
AGM Voting Results FY22-23
25.08.2022 Read More -
Q1 FY23 Press Release / News
23.08.2022 Read More -
Disclosure of Material Event – Allotment of Equity Shares on exercise of Stock options pursuant to ESOP Scheme
20.08.2022 Read More
IR & Shareholders Contact
For Shareholders:
Company Secretary
Cnergy IT Park, Unit A2, 3rd floor,
Appa Saheb Marathe Marg,
Prabhadevi, Mumbai 400 025.
India.
Tel No. 91-22-2439 5200 / 2439 5500
Fax No. 91-22-2431 5331 / 2431 5334
Email: investorelations@jbpharma.com
For Transfer/Transmission of Shares:
Datamatics Business Solutions Ltd.
Plot No. B 5, Part B Crosslane,
MIDC, Andheri (East), Mumbai 400 093.
India.
Contact Person: Mr. Satish Patil
Tel No. (022) 6671 2001-06
Fax No. (022) 6671 2011
Email: corpequity@dfssl.com
Nodal Officer for the Purpose of
Coordination with IEPF Authority:
Company Secretary
Cnergy IT Park, Unit A2, 3rd floor,
Appa Saheb Marathe Marg, Prabhadevi,
Mumbai 400 025.
India.
Tel No. 91-22-2439 5200 / 2439 5500
Fax No. 91-22-2431 5331 / 2431 5334
Email: investorelations@jbpharma.com